![FDA To Add Warning Of Rare Autoimmune Disorder To J&J Vaccine](https://img.huffingtonpost.com/asset/60ec9f4d3b0000195cecbce4.jpeg?cache=oqkbmdybcx&ops=1778_1000)
FDA To Add Warning Of Rare Autoimmune Disorder To J&J Vaccine
HuffPost
Regulators said the risk of getting Guillain-Barré syndrome from the Johnson & Johnson COVID-19 vaccine was low.
The Food and Drug Administration is expected to attach a new warning to the Johnson & Johnson COVID-19 vaccine about an increased risk of Guillain-Barré syndrome, a rare neurological disorder. Regulators said the risk of recipients developing the autoimmune disorder, which affects the nerves, was low and that the benefits of getting the vaccine against COVID-19 outweighed the risk, The New York Times reported. The Centers for Disease Control and Prevention said that about 100 cases of Guillain-Barré had been reported out of nearly 13 million people in the U.S. who got the one-dose Johnson & Johnson vaccine. Cases were primarily reported in men over age 50 and came on about two weeks after vaccination, according to The Washington Post.More Related News